참고문헌
- Leung DYM. Atopic dermatitis : New insights and opportunities for therapeutic intervention. J Allergy Clin Immunol 2000;105:860-76 https://doi.org/10.1067/mai.2000.106484
- Hong SJ, Lee MS, Sohn MH, Shim JY, Han YS, Ahn YM, et al. Self-reported prevalence and risk factors of asthma among Korean adolescents : 5-year follow-up study, 1995-2000. Clin Exp Allergy 2004;34:1556-62 https://doi.org/10.1111/j.1365-2222.2004.02084.x
- Sampson HA. Role of immediate hypersensitivity in the pathogenesis of atopic dermatitis. Allergy 1989;44(Suppl 9): 52-8
- Kapp A, Gilitzer H, Schopf E. Production of interferon and lymphoproliferative responses in whole blood culture derived from patient with atopic dermatitis. Arch Dermatol Res 1987;279:55-8 https://doi.org/10.1007/BF00585921
- Wollenberg A, Kraft S, Oppel T, Bieber T. Atopic dermatitis : pathogenetic mechanism. Clin Exp Dermatol 2000;25: 530-4 https://doi.org/10.1046/j.1365-2230.2000.00699.x
- Howard TD, Postma DS, Hawkins GA, Koppelman GH, Zheng SL, Wysong AK, et al. Fine mapping of an IgEcontrolling gene on chromosome 2q: Analysis of CTLA4 and CD28. J Allergy Clin Immunol 2002;110:743-51 https://doi.org/10.1067/mai.2002.128723
- Walunas TL, Bluestone JA. CTLA-4 regulates tolerance induction and T cell differentiation in vivo. J Immunol 1998; 160:3855-60
- Lafage-Pochitaloff M, Costello R, Couez D, Simonetti J, Mannoni P, Mawas C, et al. Human CD28 and CTLA-4 Ig superfamily genes are located on chromosome 2 at bands q33-q34. Immunogenetics 1990;31:198-201
- Brunet JF, Denizot F, Luciani MF, Roux-Dosseto M, Suzan M, Mattei MG, et al. A new member of the immunoglobulin superfamily, CTLA-4. Nature 1987;328:267-70 https://doi.org/10.1038/328267a0
- Linsley PS, Brady W, Urnes M, Grosmaire LS, Damle NK, Ledbetter JA. CTLA-4 is a second receptor for the B cell activation antigen B7. J Exp Med 1991;174:561-9 https://doi.org/10.1084/jem.174.3.561
- Freeman GJ, Gribben JG, Boussiotis VA, Ng JW, Restivo VA Jr, Lombard LA, et al. Cloning of B7-2 : a CTLA-4 counter-receptor that costimulates human T cell proliferation. Science 1993;262:909-11 https://doi.org/10.1126/science.7694363
- Azuma M, Ito D, Yagita H, Okumura K, Phillips JH, Lanier LL, et al. B70 antigen is a second ligand for CTLA-4 and CD28. Nature 1993;366:76-9 https://doi.org/10.1038/366076a0
- Ling V, Wu PW, Finnerty HF, Agostino MJ, Graham JR, Chen S, et al. Assembly and annotation of human chromosome 2q33 sequence containing the CD28, CTLA4, and ICOS gene cluster: analysis by computational, comparative, and microarray approaches. Genomics 2001;78:155-68 https://doi.org/10.1006/geno.2001.6655
- Liu X, Bai XF, Wen J, Gao JX, Liu J, Lu P, et al. B7H costimulates clonal expansion of, and cognate destruction of tumor cells by, CD8(+) T lymphocytes in vivo. J Exp Med 2001;194:1339-48 https://doi.org/10.1084/jem.194.9.1339
- Boussiotis VA, Freeman GJ, Gribben JG, Daley J, Gray G, Nadler LM. Activated human B lymphocytes express three CTLA-4 counterreceptors that costimulate T-cell activation. Proc Natl Acad Sci USA 1993;90:11059-63 https://doi.org/10.1073/pnas.90.23.11059
- Yanagawa T, Taniyama M, Enomoto S, Gomi K, Maruyama H, Ban Y, et al. CTLA4 gene polymorphism confers susceptibility to Graves' disease in Japanese. Thyroid 1997; 7:843-6 https://doi.org/10.1089/thy.1997.7.843
- Nistico L, Buzzetti R, Pritchard LE, Van der Auwera B, Giovannini C, Bosi E, et al. The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes. Belgian Diabetes Registry. Hum Mol Genet 1996; 5:1075-80 https://doi.org/10.1093/hmg/5.7.1075
- Hudson LL, Rocca K, Song YW, Pandey JP. CTLA-4 gene polymorphisms in systemic lupus erythematosus : a highly significant association with a determinant in the promoter region. Hum Genet 2002;111:452-5 https://doi.org/10.1007/s00439-002-0807-2
- Lee SY, Lee YH, Shin C, Shim JJ, Kang KH, Yoo SH, et al. Association of asthma severity and bronchial hyperresponsiveness with a polymorphism in the cytotoxic T-lymphocyte antigen-4 gene. Chest 2002;122:171-6 https://doi.org/10.1378/chest.122.1.171
- Hanifin J, Rajka G. Diagnostic features of atopic dermatitis. Acta Derma Venereol 1980;92:44-7
- European Task Force on Atopic Dermatitis. Severity scoring of atopic dermatitis : The SCORAD Index. Dermatol 1993;186:23-31 https://doi.org/10.1159/000247298
- Marsh DG, Neely JD, Breazeale DR, Ghosh B, Freidhoff LR, Ehrlich-Kautzky E, et al. Linkage analysis of IL4 and other chromosome 5q31.1 markers and total serum immunoglobulin E concentrations. Science 1994;264:1152-6 https://doi.org/10.1126/science.8178175
- Chan SC, Brown MA, Willcox TM, Li SH, Stevens SR, Tara D, et al. Abnormal IL-4 gene expression by atopic dermatitis T lymphocytes is reflected in altered nuclear protein interactions with IL-4 transcriptional regulatory element. J Invest Dermatol 1996;106:1131-6 https://doi.org/10.1111/1523-1747.ep12340181
- Kawashima T, Noguchi E, Arinami T, Yamakawa-Kobayashi K, Nakagawa H, Otsuka F, et al. Linkage and association of an interleukin 4 gene polymorphism with atopic dermatitis in Japanese families. J Med Genet 1998;35:502-4 https://doi.org/10.1136/jmg.35.6.502
- Hershey GK, Friedrich MF, Esswein LA, Thomas ML, Chatila TA. The association of atopy with a gain-of-function mutation in the alpha subunit of the interleukin-4 receptor. N Engl J Med 1997;337:1720-5 https://doi.org/10.1056/NEJM199712113372403
- Munthe-Kaas MC, Carlsen KH, Helms PJ, Gerritsen J, Whyte M, Feijen M, et al. CTLA-4 polymorphism in allergy and asthma and the Th1/Th2 paradigm. J Allergy Clin Immunol 2004;114:280-7 https://doi.org/10.1016/j.jaci.2004.03.050
- Wang XB, Zheng CY, Giscombe R, Lefvert AK. Regulation of surface and intracellular expression of CTLA-4 on human peripheral T cells. Scand J Immunol 2001;54:453-8 https://doi.org/10.1046/j.1365-3083.2001.00985.x
- Noel PJ, Boise LH, Thompson CB. Regulation of T cell activation by CD28 and CTLA4. Adv Exp Med Biol 1996;406: 209-17
- Lee YH, Choi SJ, Kim YR, Ji JD, Song GG. Polymorphism of CTLA-4 exon 1 and promoter genes in systemic lupus erythematosus and rheumatoid asthritis. J Korean Rheum Assoc 2000;7:53-61
- Pavkovic M, Georgievski B, Cevreska L, Spiroski M, Efremov DG. CTLA-4 exon 1 polymorphism in patients with autoimmune blood disorders. Am J Hematol 2003;72:147-9 https://doi.org/10.1002/ajh.10278
- Takeuchi F, Kawasugi K, Nabeta H, Mori M, Tanimoto K. Association of CTLA-4 with systemic sclerosis in Japanese patients. Clin Exp Rheumatol 2002;20:823-8
- Mora B, Bonamico M, Indovina P, Megiorni F, Ferri M, Carbone MC, et al. CTLA-4 +49 A/G dimorphism in Italian patients with celiac disease. Hum Immunol 2003;64:297-301 https://doi.org/10.1016/S0198-8859(02)00782-6
- Yang KD, Liu CA, Chang JC, Chuang H, Ou CY, Hsu TY, et al. Polymorphism of the immune-braking gene CTLA-4 (+49) involved in gender discrepancy of serum total IgE levels and allergic disease. Clin Exp Allergy 2004;34:32-7 https://doi.org/10.1111/j.1365-2222.2004.01776.x
- Wang XB, Zhao X, Giscombe R, Lefvert AK. A CTLA-4 gene polymorphism at position -318 in the promoter region affects the expression of protein. Genes Immun 2002;3:233-4 https://doi.org/10.1038/sj.gene.6363869